Administrators.

The National Institute for Health and Care Excellence (NICE) has issued revised guidance on the diagnosis and management of age-related macular degeneration (AMD), following a consultation exercise conducted during 2017. The guidance has been welcomed by the Macular Society, as it will allow the condition to be treated at an earlier stage.

You can read the full guidance documents on the NICE website. To read the Macular Society's response, click here.

The Macular Society has also produced a list of frequently asked questions about the new guidelines which you can read here.